Abstract
TRPV1 is phosphorylated and functionally upregulated by protein kinases, and negatively regulated by phosphatases including calcineurin. Since the clinical use of calcineurin-inhibiting immunosuppressants is commonly associated with chronic diarrhea, we examined if tacrolimus, a calcineurin inhibitor, promotes TRPV1-dependent colonic hypersensitivity in mice. Intracolonic administration of capsaicin, a TRPV1 agonist, caused referred hyperalgesia in the lower abdomen, an effect prevented by capsazepine, a TRPV1 blocker. Tacrolimus accelerated the intracolonic capsaicin-induced referred hyperalgesia. Similarly, intracolonic capsaicin caused spinal ERK phosphorylation, a marker for nociceptor excitation, an effect promoted by tacrolimus. Thus, tacrolimus may aggravate TRPV1-related colonic pain accompanying irritable bowel syndrome.
References
Nov 26, 1999·Nature Neuroscience·R R JiC J Woolf
Mar 24, 2004·Journal of Pharmacological Sciences·Naoyuki KawaoAtsufumi Kawabata
Oct 19, 2004·Neuroscience Research·Emiko SenbaKazue Mizumura
Jun 23, 2005·Pflügers Archiv : European journal of physiology·Makoto Tominaga, Tomoko Tominaga
Feb 7, 2008·Gut·A AkbarS Ghosh
Oct 15, 2008·Gut·M MatsunamiA Kawabata
Mar 23, 2010·The British Journal of Dermatology·U PereiraL Misery
Jun 17, 2010·Gut·Ayesha AkbarSubrata Ghosh
Oct 12, 2010·Life Sciences·Sachiyo NishimuraAtsufumi Kawabata
Nov 26, 2014·Transplantation Proceedings·E SavvidakiD S Goumenos
Jun 3, 2016·Digestive Diseases and Sciences·Yumei LuoJun Zhang
Mar 3, 2017·Pharmacology·Yuka TeradaAtsufumi Kawabata
Jun 8, 2017·Experimental Neurology·Shanwei ShenLi-Ya Qiao
Nov 27, 2018·Transplantation Reviews·Merel M TielemansLuuk B Hilbrands
Dec 24, 2018·Transplantation Proceedings·X WeiL Zhu